CRIS Current Research Information System

BARTESAGHI, RENATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.971
EU - Europa 2.525
AS - Asia 831
AF - Africa 260
SA - Sud America 5
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.959
GB - Regno Unito 662
IT - Italia 568
DE - Germania 377
CN - Cina 303
SE - Svezia 299
VN - Vietnam 224
TG - Togo 129
IN - India 126
UA - Ucraina 122
IE - Irlanda 102
FR - Francia 88
SG - Singapore 87
RU - Federazione Russa 73
CH - Svizzera 63
ZA - Sudafrica 54
JO - Giordania 45
BG - Bulgaria 43
EE - Estonia 43
CI - Costa d'Avorio 35
BE - Belgio 28
NG - Nigeria 28
NL - Olanda 17
IR - Iran 15
SC - Seychelles 13
CA - Canada 12
JP - Giappone 10
FI - Finlandia 9
GR - Grecia 9
PL - Polonia 5
TR - Turchia 5
BR - Brasile 4
ES - Italia 4
LB - Libano 4
RO - Romania 4
AU - Australia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
HR - Croazia 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
DK - Danimarca 1
HK - Hong Kong 1
IL - Israele 1
KR - Corea 1
MD - Moldavia 1
NO - Norvegia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 7.597
Salva come PNG Salva come JPEG
Città #
Southend 581
Fairfield 565
Chandler 512
Ashburn 317
Houston 274
Woodbridge 266
Wilmington 262
Seattle 247
Ann Arbor 211
Cambridge 201
Bologna 195
Dong Ket 153
Princeton 147
Lomé 129
Dublin 102
Jacksonville 78
Singapore 71
Westminster 59
Nanjing 57
Bern 56
Padova 53
Falls Church 52
Turin 51
Amman 45
Berlin 43
Frankfurt am Main 43
Sofia 43
Redmond 36
San Diego 36
Abidjan 35
Beijing 35
Shenyang 34
Abeokuta 27
Brussels 27
Saint Petersburg 26
Hebei 21
Nanchang 20
Jinan 19
Milan 17
Changsha 16
Dearborn 16
Mülheim 16
Redwood City 15
Boardman 14
Des Moines 12
Florence 12
Mahé 12
New York 12
Tianjin 12
Trento 12
Bremen 11
Rimini 11
Ardabil 10
Bristol 10
Norwalk 10
Rome 10
Toronto 10
Helsinki 9
Olalla 9
Taizhou 9
Haikou 7
London 7
Monmouth Junction 7
Udine 7
Zhengzhou 7
Hangzhou 6
Ravenna 6
Bühl 5
Forlì 5
Jiaxing 5
Lanzhou 5
Los Angeles 5
Marano 5
Paris 5
Piemonte 5
Pune 5
Tokyo 5
Argelato 4
Bolzano 4
Chicago 4
Frankfurt Am Main 4
Guangzhou 4
Hyderabad 4
Kuban 4
Kunming 4
Leawood 4
Mountain View 4
Parma 4
Phoenix 4
Sassari 4
Venezia 4
Verona 4
Andover 3
Buffalo 3
Cesena 3
Costa Mesa 3
Council Bluffs 3
Isola della Scala 3
Merone 3
Napoli 3
Totale 5.575
Salva come PNG Salva come JPEG
Nome #
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 222
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 164
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 162
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 148
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells 145
The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. 145
Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone 144
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome. 142
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 142
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 141
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 139
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 134
Neurochemical correlates of nicotine neurotoxicity on rat habenulo-interpeduncular cholinergic neurons. 131
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 131
Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice 131
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 131
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 130
null 130
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 129
Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn Mouse, an animal model for Down syndrome. 127
Postnatal neurogenesis in the dentate gyrus of the guinea pig 125
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 124
Cyclic AMP-mediated regulation of transcription factor Lot1 expression in cerebellar granule cells. 123
Topographic activation of the medial entorhinal cortex by presubicular commissural projections. 120
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 120
Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. 117
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 116
Sex differences in the stereological parameters of the hippocampal dentate gyrus of the guinea pig before puberty 115
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 114
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 114
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome 114
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 113
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 111
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 110
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling 110
Effect of early isolation on signal transfer in the entorhinal cortex-dentate-hippocampal system 109
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 109
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 107
SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation 107
Timing of therapies for downsyndrome: The sooner, the better 106
Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period. 105
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling. 105
Parallel activation of field CA2 and dentate gyrus by synaptically elicited perforant path volleys. 103
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 103
Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with Down syndrome. 102
Proliferation of cerebellar precursor cells is negatively regulated by nitric oxide in newborn rat. 101
null 100
Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation. 97
null 97
Is it possible to improve neurodevelopmental abnormalities in Down syndrome? 96
Sex differences in the hilar mossy cells of the guinea-pig before puberty. 94
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 93
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 93
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 86
null 83
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 83
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 81
Effects of early environment on field CA2 pyramidal neurons in the guinea-pig 80
Targeting APP/AICD in Down syndrome 79
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 79
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 77
Effect of early isolation on the synaptic function in the dentate gyrus and field CA1 of the guinea pig. 76
Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome 76
Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. 75
Postnatal neurogenesis in the hippocampal dentate gyrus and subventricular zone of the Goettingen minipig. 72
Input-output relations in the entorhinal cortex-dentate-hippocampal system: evidence for a non-linear transfer of signals. 70
New perspectives for the rescue of cognitive disability in down syndrome 70
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 43
Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down sindrome 41
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 33
Neurogenesis impairment: An early developmental defect in Down syndrome 32
The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives 27
Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome 23
Sex differences in the hippocampal dentate gyrus of the guinea-pig before puberty 15
Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome 9
Effects of early environment on pyramidal neuron morphology in field CA1 of the guinea-pig 7
Effects of early isolation on layer II neurons in the entorhinal cortex of the guinea pig 6
Sex differences in the hilar mossy cells of the guinea-pig before puberty 5
Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide 4
Totale 7.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.102 268 44 24 130 216 222 267 288 311 146 90 96
2020/20211.193 189 99 25 113 20 78 17 78 98 90 56 330
2021/20221.366 82 55 92 84 145 94 81 80 57 93 250 253
2022/20231.896 171 364 108 253 111 151 56 84 283 29 137 149
2023/2024489 29 83 29 50 38 100 14 22 8 36 49 31
2024/2025117 117 0 0 0 0 0 0 0 0 0 0 0
Totale 7.773